BSC
INKT icon

BOLTON SECURITIES CORPORATION’s MiNK Therapeutics INKT Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163K Hold
13,000
– – 0.01% 962
2026
Q2 		$152K Hold
13,000
– – 0.01% 982
2026
Q1 		$137K Buy
+13,000
New +$145K 0.01% 928
2025
Q3 		$182K Buy
+13,000
New +$208K 0.01% 767

Other funds holding INKT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Paladin Partners
Paladin Partners Hartland, Wisconsin $162M AUM 13.31% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Covestor
Covestor London, United Kingdom $157M AUM 35.87% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Game Plan Financial Advisors
Game Plan Financial Advisors Westlake, Ohio $264M AUM 21.06% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's INKT Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION held its MiNK Therapeutics (INKT) position steady in Q3 2026 at 13,000 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #962.

BOLTON SECURITIES CORPORATION first reported a position in INKT in Q3 2025 and has held it in 4 quarters since. The position peaked at $182K in Q3 2025. 13 funds tracked by Wall St. Rank hold INKT as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 13,000 shares of MiNK Therapeutics worth $163K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION left its MiNK Therapeutics share count unchanged in Q3 2026.
  • MiNK Therapeutics made up 0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #962 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in MiNK Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • BOLTON SECURITIES CORPORATION's MiNK Therapeutics position peaked at $182K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.